150840 — IntroMedic Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSmall Cap

Annual income statement for IntroMedic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,963	7,871	9,878	9,975	10,383
Cost of Revenue
Gross Profit	3,167	4,577	6,636	6,193	6,828
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	10,926	12,539	15,259	15,381	11,848
Operating Profit	-4,963	-4,668	-5,381	-5,406	-1,464
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-7,349	-13,854	-23,315	-6,701	-5,665
Provision for Income Taxes
Net Income After Taxes	-7,375	-13,860	-23,336	-6,709	-5,664
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-7,224	-13,742	-23,265	-6,817	-6,950
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-7,224	-13,742	-23,265	-6,817	-6,950
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-263	-399	-597	-144	-84.5
Dividends per Share